{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:39:37Z","timestamp":1785800377062,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12934-015-0202-z","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T12:53:00Z","timestamp":1423745580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems"],"prefix":"10.1186","volume":"14","author":[{"given":"Pietro","family":"Della Cristina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Barison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Ceriotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Koutris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Di Leandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giansanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Vago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Ippoliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopsamorn U","family":"Flavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Flavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colombatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Serena","family":"Fabbrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"key":"202_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrc2394","volume":"8","author":"K Strebhardt","year":"2008","unstructured":"Strebhardt K, Ullrich A. Paul Ehrlich\u2019s magic bullet concept: 100\u00a0years of progress. Nat Rev Cancer. 2008;8:473\u201380.","journal-title":"Nat Rev Cancer"},{"key":"202_CR2","doi-asserted-by":"crossref","unstructured":"Vago R, Ippoliti R; Fabbrini, M. S. Current status & Biomedical applications of Ribosome-inactivating proteins. In Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds. Edited by Ng EFFTB: Springer; 2013: 145\u2013179.","DOI":"10.1007\/978-94-007-6214-5_10"},{"key":"202_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00063030-200923010-00001","volume":"23","author":"RJ Kreitman","year":"2009","unstructured":"Kreitman RJ. Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies. BioDrugs. 2009;23:1\u201313.","journal-title":"BioDrugs"},{"key":"202_CR4","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.3390\/toxins2112699","volume":"2","author":"M de Virgilio","year":"2010","unstructured":"de Virgilio M, Lombardi A, Caliandro R, Fabbrini MS. Ribosome-inactivating proteins: from plant defense to tumor attack. Toxins (Basel). 2010;2:2699\u2013737.","journal-title":"Toxins (Basel)"},{"key":"202_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-3-642-12176-0_12","volume":"18","author":"G Fracasso","year":"2010","unstructured":"Fracasso G, Stirpe F, Colombatti M. Plant toxic proteins, ribosome - inactivating protein - containing conjugates for therapeutic use. Toxic Plant Proteins, Plant Cell Monographs. 2010;18:225\u201363.","journal-title":"Toxic Plant Proteins, Plant Cell Monographs"},{"key":"202_CR6","first-page":"4824","volume":"57","author":"DJ Flavell","year":"1997","unstructured":"Flavell DJ, Noss A, Pulford KA, Ling N, Flavell SU. Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, \u2212CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient mice. Cancer Res. 1997;57:4824\u20139.","journal-title":"Cancer Res"},{"key":"202_CR7","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood.V82.9.2624.2624","volume":"82","author":"PL Amlot","year":"1993","unstructured":"Amlot PL, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, et al. A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood. 1993;82:2624\u201333.","journal-title":"Blood"},{"key":"202_CR8","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1200\/JCO.2005.11.437","volume":"23","author":"RJ Kreitman","year":"2005","unstructured":"Kreitman RJ, Squires DR, Stetler-Stevenson M, Noel P, FitzGerald DJ, Wilson WH, et al. Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies. J Clin Oncol. 2005;23:6719\u201329.","journal-title":"J Clin Oncol"},{"key":"202_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJM200107263450402","volume":"345","author":"RJ Kreitman","year":"2001","unstructured":"Kreitman RJ, Wilson WH, Bergeron K, Raggio M, Stetler-Stevenson M, FitzGerald DJ, et al. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Engl J Med. 2001;345:241\u20137.","journal-title":"N Engl J Med"},{"key":"202_CR10","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.leukres.2014.06.014","volume":"38","author":"TK Bera","year":"2014","unstructured":"Bera TK, Onda M, Kreitman RJ, Pastan I. An improved recombinant Fab-immunotoxin targeting CD22 expressing malignancies. Leuk Res. 2014;38:1224\u20139.","journal-title":"Leuk Res"},{"key":"202_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/protein\/gzg096","volume":"16","author":"J Krauss","year":"2003","unstructured":"Krauss J, Arndt MA, Martin AC, Liu H, Rybak SM. Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment. Protein Eng. 2003;16:753\u20139.","journal-title":"Protein Eng"},{"key":"202_CR12","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1073\/pnas.1102746108","volume":"108","author":"M Onda","year":"2011","unstructured":"Onda M, Beers R, Xiang L, Lee B, Weldon JE, Kreitman RJ, et al. Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes. Proc Natl Acad Sci U S A. 2011;108:5742\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"202_CR13","doi-asserted-by":"publisher","first-page":"E3597","DOI":"10.1073\/pnas.1218138109","volume":"109","author":"R Mazor","year":"2012","unstructured":"Mazor R, Vassall AN, Eberle JA, Beers R, Weldon JE, Venzon DJ, et al. Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A. Proc Natl Acad Sci U S A. 2012;109:E3597\u2013603.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"202_CR14","doi-asserted-by":"publisher","first-page":"8571","DOI":"10.1073\/pnas.1405153111","volume":"111","author":"R Mazor","year":"2014","unstructured":"Mazor R, Eberle JA, Hu X, Vassall AN, Onda M, Beers R, et al. Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. Proc Natl Acad Sci U S A. 2014;111:8571\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"202_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/0145-2126(96)00007-0","volume":"20","author":"RR French","year":"1996","unstructured":"French RR, Bell AJ, Hamblin TJ, Tutt AL, Glennie MJ. Response of B-cell lymphoma to a combination of bispecific antibodies and saporin. Leuk Res. 1996;20:607\u201317.","journal-title":"Leuk Res"},{"key":"202_CR16","first-page":"66","volume-title":"Bacterial, Plant and Animal Toxins","author":"MSF Fabbrini","year":"2003","unstructured":"Fabbrini MSF, Flavell DJ, Ippoliti R. Plant protein toxins: structure, function and biotechnological applications. In: Ascenzi PP F, Visca P, editors. Bacterial, Plant and Animal Toxins. Kerala, India: Research Signpost; 2003. p. 66\u20139."},{"key":"202_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0003-2697(92)90433-8","volume":"205","author":"J Buchner","year":"1992","unstructured":"Buchner J, Pastan I, Brinkmann U. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal Biochem. 1992;205:263\u201370.","journal-title":"Anal Biochem"},{"key":"202_CR18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1182\/blood.V69.3.836.836","volume":"69","author":"DY Mason","year":"1987","unstructured":"Mason DY, Stein H, Gerdes J, Pulford KA, Ralfkiaer E, Falini B, et al. Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells. Blood. 1987;69:836\u201340.","journal-title":"Blood"},{"key":"202_CR19","first-page":"3995","volume":"63","author":"MG Rosenblum","year":"2003","unstructured":"Rosenblum MG, Cheung LH, Liu Y, Marks 3rd JW. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin. Cancer Res. 2003;63:3995\u20134002.","journal-title":"Cancer Res"},{"key":"202_CR20","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/1535-7163.MCT-10-0203","volume":"9","author":"DA Vallera","year":"2010","unstructured":"Vallera DA, Oh S, Chen H, Shu Y, Frankel AE. Bioengineering a unique deimmunized bispecific targeted toxin that simultaneously recognizes human CD22 and CD19 receptors in a mouse model of B-cell metastases. Mol Cancer Ther. 2010;9:1872\u201383.","journal-title":"Mol Cancer Ther"},{"key":"202_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/protein\/gzp070","volume":"23","author":"F Giansanti","year":"2010","unstructured":"Giansanti F, Di Leandro L, Koutris I, Pitari G, Fabbrini MS, Lombardi A, et al. Engineering a switchable toxin: the potential use of PDZ domains in the expression, targeting and activation of modified saporin variants. Protein Eng, Des Sel. 2010;23:61\u20138.","journal-title":"Protein Eng, Des Sel"},{"key":"202_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/ijc.10809","volume":"103","author":"I Heisler","year":"2003","unstructured":"Heisler I, Keller J, Tauber R, Sutherland M, Fuchs H. A cleavable adapter to reduce nonspecific cytotoxicity of recombinant immunotoxins. Int J Cancer. 2003;103:277\u201382.","journal-title":"Int J Cancer"},{"key":"202_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1574-6976.2000.tb00532.x","volume":"24","author":"JL Cereghino","year":"2000","unstructured":"Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev. 2000;24:45\u201366.","journal-title":"FEMS Microbiol Rev"},{"key":"202_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1046-5928(02)00009-8","volume":"25","author":"JH Woo","year":"2002","unstructured":"Woo JH, Liu YY, Mathias A, Stavrou S, Wang Z, Thompson J, et al. Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris. Protein Expr Purif. 2002;25:270\u201382.","journal-title":"Protein Expr Purif"},{"key":"202_CR25","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1128\/AEM.66.4.1572-1579.2000","volume":"66","author":"S Barth","year":"2000","unstructured":"Barth S, Huhn M, Matthey B, Klimka A, Galinski EA, Engert A. Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions. Appl Environ Microbiol. 2000;66:1572\u20139.","journal-title":"Appl Environ Microbiol"},{"key":"202_CR26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/protein\/6.8.989","volume":"6","author":"M Whitlow","year":"1993","unstructured":"Whitlow M, Bell BA, Feng SL, Filpula D, Hardman KD, Hubert SL, et al. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. Protein Eng. 1993;6:989\u201395.","journal-title":"Protein Eng"},{"key":"202_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-313X.2010.04413.x","volume":"65","author":"RS Marshall","year":"2011","unstructured":"Marshall RS, D\u2019Avila F, Di Cola A, Traini R, Spano L, Fabbrini MS, et al. Signal peptide-regulated toxicity of a plant ribosome-inactivating protein during cell stress. Plant J. 2011;65:218\u201329.","journal-title":"Plant J"},{"key":"202_CR28","volume-title":"Toxic plant proteins, plant cell monographs","author":"RS Lombardi AM","year":"2010","unstructured":"Lombardi AM RS, Savino C, Fabbrini MS, Ceriotti A. Toxic plant proteins, plant cell monographs. Berlin\/Heidelberg, Germany: Springer; 2010."},{"key":"202_CR29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1096\/fasebj.14.2.391","volume":"14","author":"MS Fabbrini","year":"2000","unstructured":"Fabbrini MS, Carpani D, Soria MR, Ceriotti A. Cytosolic immunization allows the expression of preATF-saporin chimeric toxin in eukaryotic cells. FASEB J. 2000;14:391\u20138.","journal-title":"FASEB J"},{"key":"202_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1096\/fj.08-118042","volume":"24","author":"A Lombardi","year":"2010","unstructured":"Lombardi A, Bursomanno S, Lopardo T, Traini R, Colombatti M, Ippoliti R, et al. Pichia pastoris as a host for secretion of toxic saporin chimeras. FASEB J. 2010;24:253\u201365.","journal-title":"FASEB J"},{"key":"202_CR31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1110\/ps.0228503","volume":"12","author":"BE Power","year":"2003","unstructured":"Power BE, Doughty L, Shapira DR, Burns JE, Bayly AM, Caine JM, et al. Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody. Protein Sci. 2003;12:734\u201347.","journal-title":"Protein Sci"},{"key":"202_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00253-011-3118-5","volume":"90","author":"CJ Huang","year":"2011","unstructured":"Huang CJ, Damasceno LM, Anderson KA, Zhang S, Old LJ, Batt CA. A proteomic analysis of the Pichia pastoris secretome in methanol-induced cultures. Appl Microbiol Biotechnol. 2011;90:235\u201347.","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-015-0202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12934-015-0202-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-015-0202-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-015-0202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T08:34:50Z","timestamp":1630571690000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-015-0202-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1186\/s12934-015-0202-z","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]},"assertion":[{"value":"21 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}